Stock CNWK CO.DON AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials co.don AG Xetra

Equities

CNWK

DE000A1K0227

Pharmaceuticals

End-of-day quote Xetra
Other stock markets
 06:00:00 2022-09-29 pm EDT 		5-day change 1st Jan Change
0.245 EUR -28.99% Intraday chart for co.don AG -25.76% -.--%

Valuation

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Capitalization 1 45.42 134.9 62.84 41.32 45.16 33.89
Enterprise Value (EV) 1 43.44 122.3 62.07 46.78 42.02 33.6
P/E ratio -12.4 x -19.1 x -5.8 x -3.22 x -2.91 x -3.8 x
Yield - - - - - -
Capitalization / Revenue 8.08 x 22.6 x 11 x 5.98 x 7.25 x 3.46 x
EV / Revenue 7.73 x 20.4 x 10.9 x 6.77 x 6.74 x 3.43 x
EV / EBITDA -12.7 x -18 x -7.47 x -5.12 x -4.77 x -4.37 x
EV / FCF -17 x -17 x -4.75 x -3.47 x -5.05 x -5.92 x
FCF Yield -5.88% -5.88% -21% -28.8% -19.8% -16.9%
Price to Book 16.4 x 8.34 x 4.94 x 4.01 x 2.63 x 2.36 x
Nbr of stocks (in thousands) 8,110 9,730 9,850 10,873 18,211 21,865
Reference price 2 5.600 13.87 6.380 3.800 2.480 1.550
Announcement Date 4/26/17 5/22/18 5/26/20 5/26/20 5/4/21 7/8/22
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales 1 5.622 5.98 5.696 6.907 6.233 9.803
EBITDA 1 -3.41 -6.796 -8.307 -9.14 -8.809 -7.694
EBIT 1 -3.651 -7.043 -8.561 -9.448 -9.137 -8.427
Operating Margin -64.95% -117.77% -150.3% -136.79% -146.59% -85.96%
Earnings before Tax (EBT) 1 -3.65 -7.054 -4.996 -13.16 -14.58 -9.136
Net income 1 -3.65 -7.054 -6.271 -12.63 -13.87 -9.322
Net margin -64.93% -117.96% -110.09% -182.84% -222.51% -95.09%
EPS 2 -0.4502 -0.7250 -1.100 -1.180 -0.8512 -0.4083
Free Cash Flow 1 -2.554 -7.19 -13.06 -13.47 -8.318 -5.671
FCF margin -45.43% -120.24% -229.26% -195.06% -133.45% -57.85%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/26/17 5/22/18 5/26/20 5/26/20 5/4/21 7/8/22
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt 1 - - - 5.46 - -
Net Cash position 1 1.98 12.6 0.77 - 3.15 0.29
Leverage (Debt/EBITDA) - - - -0.5974 x - -
Free Cash Flow 1 -2.55 -7.19 -13.1 -13.5 -8.32 -5.67
ROE (net income / shareholders' equity) -79.6% -74.5% -43.5% -104% -86.3% -48.8%
ROA (Net income/ Total Assets) -37% -38% -23.1% -22.6% -21.2% -19%
Assets 1 9.868 18.58 27.17 55.87 65.38 48.96
Book Value Per Share 2 0.3400 1.660 1.290 0.9500 0.9400 0.6600
Cash Flow per Share 2 0.2400 0.2700 1.040 0.3300 0.4200 0.2400
Capex 1 0.17 3.95 6.98 3.34 0.52 0.22
Capex / Sales 3.01% 66.1% 122.51% 48.33% 8.31% 2.2%
Announcement Date 4/26/17 5/22/18 5/26/20 5/26/20 5/4/21 7/8/22
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
CSL LIMITED Stock CSL Limited
-4.66% 86.13B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 39.82B
BIOGEN INC. Stock Biogen Inc.
-19.27% 30.42B
UCB Stock UCB
+57.86% 25.23B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.09% 15.35B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.14% 11.95B
INCYTE CORPORATION Stock Incyte Corporation
-17.69% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.00% 11.51B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.24% 8.71B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. CNW Stock
  4. CNWK Stock
  5. Financials co.don AG